Solana

HSDT · NASDAQ

$2.33+$0.09 (+4.02%)TodayMarket closed ·
Prev close $2.24

About HSDT

Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The company is headquartered in Newtown, Pennsylvania and currently employs 21 full-time employees. The company went IPO on 2014-06-27. The company is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. The company offers public market investors optimal exposure to Solana’s secular growth. The company has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. The company will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.

Employees
21
Headquarters
Newtown, Pennsylvania
Listed
Jun 27, 2014
Sector
Health Care
Industry
Health Care Equipment & Supplies

HSDT key statistics

Market cap
141.51M
Price-earnings ratio
0.04
Dividend yield
—
Average volume
637.15K
Volume
617.15K
Open price
$2.21
High today
$2.37
Low today
$2.21
52 Week high
$7.21
52 Week low
$1.19

Solana (HSDT) at a glance

Solana (HSDT) last traded at $2.33, with a market cap of 141.51M and a price-to-earnings ratio of 0.04.

Today the stock has traded between $2.21 and $2.37. The current price is 5.4% above the day's low and 1.7% below its high.

Volume so far is 617.15K shares, in line with the average of 637.15K shares a day.

Over the past year Solana has ranged from $1.19 to $7.21, and now sits 19% of the way up that range.

Solana met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported -$0.08 per share against an estimate of -$0.0204.

The average analyst price target is $3.57, 53.2% above the current price, from 2 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 2 analyst ratings say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 4 analystsAvg $3.57
Low
$3.03
Now
$2.33
High
$4.20

HSDT earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 50.5% on average.

  1. Q2 FY24: reported -$480.00 per share against an estimate of -$382.50
  2. Q3 FY24: reported -$742.50 per share against an estimate of -$810.90
  3. Q4 FY24: reported -$765.00 per share against an estimate of -$719.10
  4. Q1 FY25: reported -$382.50 per share against an estimate of -$443.70
  5. Q2 FY25: reported -$79.73 per share against an estimate of -$131.07
  6. Q3 FY25: reported $20.84 per share against an estimate of -$51.51
  7. Q1 FY26: reported -$1.30 per share against an estimate of -$0.4896
  8. Q2 FY26: reported -$0.08 per share against an estimate of -$0.0204

HSDT news

  • Aniket Verma

    China vs. Crypto Isn’t Over Yet: Solana Company CEO Says Beijing Is Studying the Technology ‘Very Closely’ — 'They Know That's Not the Technology They Can Ignore'

  • Full Transcript: Helius Medical Tech Q2 2026 Earnings Call

  • Press releaseGlobe Newswire

    Solana Company to Release Second Quarter 2026 Operating Results on August 14, 2026

  • Press releaseGlobe Newswire

    Solana Company Partners with Alatau City to Advance Digital Asset Infrastructure and Blockchain Adoption in Central Asia

  • Helius Medical Tech Reports Q1 2026 Results: Full Earnings Call Transcript

  • Press releaseGlobe Newswire

    Solana Company Reports First Quarter 2026 Financial Results

  • Press releaseGlobe Newswire

    Solana Company to Release First Quarter 2026 Operating Results on May 15, 2026

  • Press releaseGlobe Newswire

    Solana Company Reports Fourth Quarter and Full Year 2025 Financial Results

Similar companies

Companies in the same industry as Solana

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.